Literature DB >> 21413079

Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRI.

Benjamin M Ellingson1, Peter S LaViolette, Scott D Rand, Mark G Malkin, Jennifer M Connelly, Wade M Mueller, Robert W Prost, Kathleen M Schmainda.   

Abstract

The purpose of this study was to develop a voxel-wise analytical solution to a glioma growth model using serial diffusion MRI. These cell invasion, motility, and proliferation level estimates (CIMPLE maps) provide quantitative estimates of microscopic tumor growth dynamics. After an analytical solution was found, noise simulations were performed to predict the effects that perturbations in apparent diffusion coefficient values and the time between apparent diffusion coefficient map acquisitions would have on the accuracy of CIMPLE maps. CIMPLE maps were then created for 53 patients with gliomas with WHO grades of II-IV. MR spectroscopy estimates of the choline-to-N-acetylaspartate ratio were compared to cell proliferation estimates in CIMPLE maps using Pearson's correlation analysis. Median differences in cell proliferation and diffusion rates between WHO grades were compared. A strong correlation (R(2) = 0.9714) and good spatial correspondence were observed between MR spectroscopy measurements of the choline-to-N-acetylaspartate ratio and CIMPLE map cell proliferation rate estimates. Estimates of cell proliferation and diffusion rates appear to be significantly different between low- (WHO II) and high-grade (WHO III-IV) gliomas. Cell diffusion rate (motility) estimates are highly dependent on the time interval between apparent diffusion coefficient map acquisitions, whereas cell proliferation rate estimates are additionally influenced by the level of noise present in apparent diffusion coefficient maps.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21413079      PMCID: PMC3065939          DOI: 10.1002/mrm.22688

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  29 in total

1.  Real-time 3D image registration for functional MRI.

Authors:  R W Cox; A Jesmanowicz
Journal:  Magn Reson Med       Date:  1999-12       Impact factor: 4.668

2.  Quantifying efficacy of chemotherapy of brain tumors with homogeneous and heterogeneous drug delivery.

Authors:  Kristin R Swanson; Ellsworth C Alvord; J D Murray
Journal:  Acta Biotheor       Date:  2002       Impact factor: 1.774

3.  The role of diffusion-weighted imaging in patients with brain tumors.

Authors:  K Kono; Y Inoue; K Nakayama; M Shakudo; M Morino; K Ohata; K Wakasa; R Yamada
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

4.  Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging.

Authors:  K M Gauvain; R C McKinstry; P Mukherjee; A Perry; J J Neil; B A Kaufman; R J Hayashi
Journal:  AJR Am J Roentgenol       Date:  2001-08       Impact factor: 3.959

5.  Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity.

Authors:  Benjamin M Ellingson; Mark G Malkin; Scott D Rand; Jennifer M Connelly; Carolyn Quinsey; Pete S LaViolette; Devyani P Bedekar; Kathleen M Schmainda
Journal:  J Magn Reson Imaging       Date:  2010-03       Impact factor: 4.813

6.  A quantitative model for differential motility of gliomas in grey and white matter.

Authors:  K R Swanson; E C Alvord; J D Murray
Journal:  Cell Prolif       Date:  2000-10       Impact factor: 6.831

7.  Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.

Authors:  T L Chenevert; L D Stegman; J M Taylor; P L Robertson; H S Greenberg; A Rehemtulla; B D Ross
Journal:  J Natl Cancer Inst       Date:  2000-12-20       Impact factor: 13.506

8.  Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging.

Authors:  H Lyng; O Haraldseth; E K Rofstad
Journal:  Magn Reson Med       Date:  2000-06       Impact factor: 4.668

9.  Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma.

Authors:  Damien Galanaud; Olivier Chinot; François Nicoli; Sylviane Confort-Gouny; Yann Le Fur; Maryline Barrie-Attarian; Jean-Philippe Ranjeva; Stéphane Fuentès; Patrick Viout; Dominique Figarella-Branger; Patrick J Cozzone
Journal:  J Neurosurg       Date:  2003-02       Impact factor: 5.115

Review 10.  Cost of migration: invasion of malignant gliomas and implications for treatment.

Authors:  A Giese; R Bjerkvig; M E Berens; M Westphal
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

View more
  22 in total

1.  Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma.

Authors:  Benjamin M Ellingson; Timothy F Cloughesy; Taryar Zaw; Albert Lai; Phioanh L Nghiemphu; Robert Harris; Shadi Lalezari; Naveed Wagle; Kourosh M Naeini; Jose Carrillo; Linda M Liau; Whitney B Pope
Journal:  Neuro Oncol       Date:  2012-01-22       Impact factor: 12.300

2.  Integration of diffusion-weighted MRI data and a simple mathematical model to predict breast tumor cellularity during neoadjuvant chemotherapy.

Authors:  Nkiruka C Atuegwu; Lori R Arlinghaus; Xia Li; E Brian Welch; Bapsi A Chakravarthy; John C Gore; Thomas E Yankeelov
Journal:  Magn Reson Med       Date:  2011-09-28       Impact factor: 4.668

3.  Clinically relevant modeling of tumor growth and treatment response.

Authors:  Thomas E Yankeelov; Nkiruka Atuegwu; David Hormuth; Jared A Weis; Stephanie L Barnes; Michael I Miga; Erin C Rericha; Vito Quaranta
Journal:  Sci Transl Med       Date:  2013-05-29       Impact factor: 17.956

4.  Predicting in vivo glioma growth with the reaction diffusion equation constrained by quantitative magnetic resonance imaging data.

Authors:  David A Hormuth; Jared A Weis; Stephanie L Barnes; Michael I Miga; Erin C Rericha; Vito Quaranta; Thomas E Yankeelov
Journal:  Phys Biol       Date:  2015-06-04       Impact factor: 2.583

5.  Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diffusion MR images in recurrent glioblastoma treated with bevacizumab.

Authors:  Benjamin M Ellingson; Timothy F Cloughesy; Albert Lai; Phioanh L Nghiemphu; Whitney B Pope
Journal:  J Neurooncol       Date:  2011-03-26       Impact factor: 4.130

6.  Integrated Biophysical Modeling and Image Analysis: Application to Neuro-Oncology.

Authors:  Andreas Mang; Spyridon Bakas; Shashank Subramanian; Christos Davatzikos; George Biros
Journal:  Annu Rev Biomed Eng       Date:  2020-06-04       Impact factor: 9.590

7.  Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy.

Authors:  Benjamin M Ellingson; Timothy F Cloughesy; Albert Lai; Phioanh L Nghiemphu; Linda M Liau; Whitney B Pope
Journal:  Neuro Oncol       Date:  2012-12-28       Impact factor: 12.300

Review 8.  An Update on the Approach to the Imaging of Brain Tumors.

Authors:  Katherine M Mullen; Raymond Y Huang
Journal:  Curr Neurol Neurosci Rep       Date:  2017-07       Impact factor: 5.081

9.  Serial diffusion MRI to monitor and model treatment response of the targeted nanotherapy CRLX101.

Authors:  Thomas S C Ng; David Wert; Hargun Sohi; Daniel Procissi; David Colcher; Andrew A Raubitschek; Russell E Jacobs
Journal:  Clin Cancer Res       Date:  2013-03-26       Impact factor: 12.531

Review 10.  Imaging biomarkers for antiangiogenic therapy in malignant gliomas.

Authors:  Kevin Leu; Whitney B Pope; Timothy F Cloughesy; Albert Lai; Phioanh L Nghiemphu; Wei Chen; Linda M Liau; Benjamin M Ellingson
Journal:  CNS Oncol       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.